Accelrys, Inc. develops and commercializes scientific business intelligence software and solutions in the United States, Europe, and the Asia Pacific. The company offers scientific platform and data management to design, develop, and deploy scientific informatics software solutions. It also offers modeling and simulation software products that allows scientists to perform computations of chemical, biological, and materials properties; to simulate, visualize, and analyze chemical and biological systems; and to communicate the results to other scientists. In addition, the company provides software-based research informatics solutions designed to capture, store, manage, analyze, mine, and repor...
5005 Wateridge Vista Drive
San Diego, CA 92121
Founded in 1993
Accelrys Inc.(NasdaqGM:ACCL) dropped from Russell 2000 Index
May 1 14
Accelrys Inc. will be removed from the Russell 2000 Index.
Accelrys Inc.(NasdaqGM:ACCL) dropped from Russell 3000 Index
May 1 14
Accelrys Inc. will be removed from the Russell 3000 Index.
Accelrys Inc. Announces Board Changes
Apr 29 14
As previously disclosed in the Current Report on Form 8-K filed by Accelrys Inc. (the 'company'), with the Securities and Exchange Commission) on January 30, 2014, the Company entered into an Agreement and Plan of Merger (the 'Merger Agreement'), dated as of January 30, 2014, with Dassault Systemes Americas Corp., a Delaware corporation (Parent), and 3DS Acquisition Corp., a Delaware corporation and wholly owned subsidiary of Parent (Purchaser). In accordance with the terms of the Merger Agreement, the directors of Purchaser immediately prior to the Effective Time, which consisted of Bernard Charlès, Thibault de Tersant and Deborah Dean, automatically became the directors of the company, in each case, effective as of the Effective Time. Accordingly, Chris van Ingen, Max Carnecchia, Larry Ferguson, Timothy Harkness, Heidi Melin and Jeffrey Rodek are no longer directors of the company.